Literature DB >> 21501965

Down syndrome: issues to consider in a national registry, research database and biobank.

Linda L McCabe1, Edward R B McCabe.   

Abstract

As the quality of life for individuals with Down syndrome continues to improve due to anticipatory healthcare, early intervention, mainstreaming in schools, and increased expectations, the lack of basic information regarding individuals with Down syndrome is being recognized, and the need to facilitate research through a national registry, research database and biobank is being discussed. We believe that there should not be ownership of the samples and information, but instead prefer stewardship of the samples and information to benefit the participants who provided them. We endorse a model with data and sample managers and a research review board to interface between the investigators and participants. Information and samples would be coded, and only a few data managers would know the relationship between the codes and identifying information. Research results once published should be included in an online newsletter. If appropriate, individual results should be shared with participants. A Down syndrome registry, research database and biobank should be accountable to participants, families, medical care providers, government, and funding sources.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21501965     DOI: 10.1016/j.ymgme.2011.03.018

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  6 in total

1.  Down syndrome: national conference on patient registries, research databases, and biobanks.

Authors:  Mary Lou Oster-Granite; Melissa A Parisi; Leonard Abbeduto; Dorit S Berlin; Cathy Bodine; Dana Bynum; George Capone; Elaine Collier; Dan Hall; Lisa Kaeser; Petra Kaufmann; Jeffrey Krischer; Michelle Livingston; Linda L McCabe; Jill Pace; Karl Pfenninger; Sonja A Rasmussen; Roger H Reeves; Yaffa Rubinstein; Stephanie Sherman; Sharon F Terry; Michelle Sie Whitten; Stephen Williams; Edward R B McCabe; Yvonne T Maddox
Journal:  Mol Genet Metab       Date:  2011-07-13       Impact factor: 4.797

2.  Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Daniel Ferguson; Rachael Hageman Blair; James L Kalabus; Almedina Redzematovic; Javier G Blanco
Journal:  Pharm Res       Date:  2014-02-22       Impact factor: 4.200

3.  Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.

Authors:  Erik Hefti; Adolfo Quiñones-Lombraña; Almedina Redzematovic; Jeffrey Hui; Javier G Blanco
Journal:  Mitochondrial DNA A DNA Mapp Seq Anal       Date:  2014-06-18       Impact factor: 1.514

4.  Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies.

Authors:  Beth A Tarini; John D Lantos
Journal:  Per Med       Date:  2013-01-01       Impact factor: 2.512

5.  Analysis of the intracellular traffic of IgG in the context of Down syndrome (trisomy 21).

Authors:  R B Cejas; M Tamaño-Blanco; J G Blanco
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

6.  Alterations and chromosomal variants in the Ecuadorian population.

Authors:  César Paz-y-Miño; Nadia Cumbal; Santiago Araujo; Ma Eugenia Sánchez
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.